Articles citing this paper
Abacavir exposure and cardiovascular risk factors in HIV-positive patients with coronary heart disease: a retrospective case–control study
Janine M. Trevillyan A C , Allen C. Cheng A B and Jennifer Hoy A B
+ Author Affiliations
- Author Affiliations
A Infectious Diseases Unit, The Alfred Hospital, 55 Commercial Road, Melbourne, Vic. 3004, Australia.
B Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Vic. 3145, Australia.
C Corresponding author. Email: j.trevillyan@alfred.org.au
Sexual Health 10(2) 97-101 https://doi.org/10.1071/SH12081
Submitted: 1 June 2012 Accepted: 16 September 2012 Published: 21 December 2012
8 articles found in Crossref database.
Porphyromonas gingivalis antibody levels and diagnosis of coronary artery disease in HIV‐positive individuals
Berquist V. L.,
Hearps A. C.,
Ford P.,
Jaworowski A.,
Leishman S. J.,
Hoy J. F., Trevillyan J. M.
Journal of Periodontal Research. 2017 52(5). p.930
Protecting the heart after HAART; understanding the pathogenesis of cardiovascular disease in people living with HIV
Trevillyan Janine M, Hoy Jennifer F
Microbiology Australia. 2014 35(2). p.91
Differential Adipose Tissue Gene Expression Profiles in Abacavir Treated Patients That May Contribute to the Understanding of Cardiovascular Risk: A Microarray Study
Shahmanesh Mohsen,
Phillips Kenneth,
Boothby Meg,
Tomlinson Jeremy W., Gray Clive M.
PLOS ONE. 2015 10(1). p.e0117164
Plasma Lipidomic Profiling of Treated HIV-Positive Individuals and the Implications for Cardiovascular Risk Prediction
Wong Gerard,
Trevillyan Janine M.,
Fatou Benoit,
Cinel Michelle,
Weir Jacquelyn M.,
Hoy Jennifer F.,
Meikle Peter J., Monleon Daniel
PLoS ONE. 2014 9(4). p.e94810
Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies
Dorjee Kunchok,
Choden Tsering,
Baxi Sanjiv M.,
Steinmaus Craig, Reingold Arthur L.
International Journal of Antimicrobial Agents. 2018 52(5). p.541
Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals
Trevillyan J. M.,
Gardiner E. E.,
Andrews R. K.,
Maisa A.,
Hearps A. C.,
Al-Tamimi M.,
Crowe S. M., Hoy J. F.
Platelets. 2017 28(3). p.301
Are antiretrovirals enough for people living with HIV?
Phillips Andrew,
Baker Jason, Lundgren Jens
The Lancet. 2013 382(9903). p.1466
Contribution of antiretroviral therapy to cardiovascular disease risk in HIV-infected patients
Burrowes Shana,
Cahill Patrick,
Kottilil Shyamasundaran, Bagchi Shashwatee
Future Virology. 2016 11(7). p.509
